PHARMA VAL
Timeline
14 events since 2018Board
Filings
Financial
Establishments
20182020202220242026
The 2026 accounts are due by 31-07-2027.
2026
Annual accounts 2025 filed PDFmicro format · 73 days before the deadline
2025
Registered in the Peppol Directory Reachable for e-invoices through 0208:0700328914
Annual accounts 2024 filed PDFmicro format · 111 days before the deadline
2024
Weakest financial year net €8,243 ▼65.7% The net result drops to €8,243, the lowest from 2019 to 2025. It recovers the following year.
Annual accounts 2023 filed PDFmicro format · 131 days before the deadline
2023
Equity above €200,000 equity €206,913 ▲12.6% With a profit in every financial year since 2019, equity grows to €206,913.
Annual accounts 2022 filed PDFmicro format · 1 day late
2022
Resignation: (director)Reappointment: (director) · “Les prestations rémunérées en officine; L’exploitation de pharmacies et de laboratoires d’analyses ainsi que…” (deed in French) · is a shareholder · General meeting of 13-07-20229 points ▸
- Registered office clause, chaussée de Dinant 11, 5170 Profondeville
- is a shareholder
- Purpose change, “Les prestations rémunérées en officine; L’exploitation de pharmacies et de laboratoires d’analyses ainsi que le commerce dans son sens le plus large; 1.de tous…” (deed in French), mentioned twice in the deed
- General meeting, 13-07-2022
- Legal-form conversion, from private limited company (pre-2019) to private limited company
- 100 shares
- Director resignation,
- Director reappointment, (director (not named in the articles))
- Director discharge,
- The deed holds 7 more points.
Annual accounts 2021 filed PDFmicro format · 47 days before the deadline
2021
Equity above €150,000 equity €170,911 ▲19.7% With a profit in every financial year since 2019, equity grows to €170,911.
Annual accounts 2020 filed PDFmicro format · 109 days before the deadline
2020
Annual accounts 2019 filed PDFmicro format · 45 days before the deadline
2018
IncorporationFounding capital of €18,600, 100 shares, €12,400 paid up · Founder: (comparant) · Appointment: (manager) · published on 25-07-20185 points ▸
- Founder, (comparant)
- Founding capital, €18,600, 100 shares
- Capital, €18,600, 100 shares
- Director appointment, (manager (not named in the articles))
- Permanent representative,
- The deed holds 3 more points.
First establishment Chaussée de Dinant 11, Profondeville
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank